Current Pharmaceutical Design

320.1k citations
9.9k papers · · active since 1950

Impact in

Papers in

Current Pharmaceutical Design

8.6k papers receiving 288.4k citations

Peers

Current Pharmaceutical Design
Comparison fields: 5 of 238
  • Biological Psychiatry 5.6k
  • Molecular Biology 111.7k
  • Pharmacology 24.0k
  • Molecular Medicine 6.8k
  • Cancer Research 17.7k
Replace Current Medicinal Chemistry with:
Current Medicinal Chemistry Italy
Pharmacological Research Italy
Frontiers in Pharmacology China
International Immunopharmacology China
Advances in experimental medicine and biology United States
Nature Reviews Drug Discovery United States
Biomedicine & Pharmacotherapy China
Pharmacology & Therapeutics United States
Gut United Kingdom
Experimental Biology and Medicine United States
Current Pharmaceutical Design relative to Current Medicinal Chemistry Italy Current Medicinal Chemistry's profile →
Citations per field
00.5×1.7×
Current Medicinal Chemistry · 1×
Citations per year

Countries where authors publish in Current Pharmaceutical Design

Since Specialization
Citations

This map shows the geographic impact of research published in Current Pharmaceutical Design. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Current Pharmaceutical Design with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Current Pharmaceutical Design more than expected).

Fields of papers published in Current Pharmaceutical Design

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Current Pharmaceutical Design. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Current Pharmaceutical Design.

About Current Pharmaceutical Design

The 9.9k papers published in Current Pharmaceutical Design in the last decades have received a total of 320.1k indexed citations . Papers published in Current Pharmaceutical Design usually cover Pharmaceutical Science (354 papers), Biological Psychiatry (129 papers), Pharmacology (708 papers), Molecular Biology (2.9k papers) and Cancer Research (533 papers) specifically the topics of Computational Drug Discovery Methods (364 papers), Nanoparticle-Based Drug Delivery (282 papers), RNA Interference and Gene Delivery (238 papers), Monoclonal and Polyclonal Antibodies Research (211 papers), Advanced Drug Delivery Systems (174 papers), Receptor Mechanisms and Signaling (153 papers), Neuroscience and Neuropharmacology Research (146 papers) and Lipoproteins and Cardiovascular Health (144 papers). The most active scholars publishing in Current Pharmaceutical Design are Claudiu T. Supuran, Sho‐ichi Yamagishi, Amirhossein Sahebkar, K. Hüsnü Can Başer, William A. Banks, Michael J. Rogers, David J. Begley, James E. Klaunig, Anne Pihlanto and Hannu T. Korhonen.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact